Stefan Bernstein explains how the EU/Greenland critical raw materials partnership benefits GreenRoc. Watch the full video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Davey50
be pragmatic..... Monoclonal antibodies market size is over $200B
just 1% of this is worth over $2b US Dollars, which means a staggering upside for FAB......
yet you do not perceive this Knowledge or can't comprehend or process this Potential in your Brian.
let this sink in!!!!
Https://www.biospace.com/article/releases/cancer-monoclonal-antibodies-market-size-estimated-to-reach-usd-410-95-billion-by-2032/
Does not matter what number you "pluck out"...you do not hold anything more than 1-2 days max, your twitter account is just a pump and dumpathon. Everybody knows it too, you get lucky at times like we all do but everybody knows you'll sell out just as quickly as you bought in so all your numbers and million bagger posts mean nothing.
Davy50
look at this before making silly comments.......
$200b isn't a figure I plucked out of thin air!!!
Https://www.biospace.com/article/releases/cancer-monoclonal-antibodies-market-size-estimated-to-reach-usd-410-95-billion-by-2032/
I'm surprised Company don't know this yet or Haven't Rns the Monoclonal Antibodies Market Size yet.......
Google "What is the market size for Monoclonal Antibodies"
it's over $200 billion dollar industry and rising to ¥500billion in the next few years.
only 1% of the market share is worth a look at staggering £2Billion
yes two Billion dollars.
market is missing this
Seriously Earl why do you bother, everybody knows you dump for less than 5%. Every week you take over a thread, say the stock is worth billions or a 100-1000 bagger then a clump of sales all appear within seconds and you vanish and never post again. We all how you operate Earl, is there any mugs left on this forum to rob ?
£1B market cap =‘s £10.50+ SP ! 😳😃
NCI
national trust cancer Institute in the USA
collaboration since November 2023, since then no update yet, so most likely will be an update soon
News coming soon on this collaboration update......
OptiMAL® collaboration agreement
Fusion Antibodies plc (AIM: FAB), specialists in pre-clinical antibody discovery, engineering and supply for both therapeutic drug and diagnostic applications, announces that it has signed a collaboration agreement (the "Agreement") with the National Cancer Institute ("NCI") for the use of OptiMAL® in the discovery of novel antibodies against targets selected by NCI.
Under the terms of the Agreement, Fusion will provide access to the OptiMAL® technology to NCI for deployment against an agreed number of targets, being primarily cancer targets, over a period of up to two years, in order to develop potential therapeutic antibodies against the selected targets. The parties will work together to ensure successful validation of the OptiMAL® technology and jointly publish any results from the collaboration. The validation will be run at NCI's laboratories by their staff and antibodies identified pursuant to the Agreement would be retained by NCI.
Price should be higher. Big players were buying a lot higher
Sub 4 cleared out now
Funds managers are looking to invest in Bio Tech
https://www.thisismoney.co.uk/money/diyinvesting/article-13227289/Im-fund-manager-biotech-investor-Ailsa-Craig-thinks-rate-cuts-spark-rebound.html
Billions worth
Monoclonal Antibodies Market: The global monoclonal antibodies market size accounted for USD 201.63 billion in 2022 and is projected to hit around USD 634.64 billion by 2032, poised to grow at a CAGR of 12.2% over the forecast period from 2023 to 2032
Lots of high profile stuff starting today
Worked buy orders as price was NT for so long at 3.90, price ticked up blue bang on 4.19 when the 2nd of the 250k was reported. And into close the bid was the strongest it had been all day. Looking good to break back over 4.
Fusion-antibiotics-plc
just needs 1% share of the $200 Billion market share for the Monoclonal Antibodies 😳
Mcap £3m is ridiculously cheap for that sort of potential.
Mcap should go to £15m at least on the potential value
then when Contracts starts to come Sp can shoot up exponentially
Has anyone seen this
Monoclonal Antibodies Market: The global monoclonal antibodies market size accounted for USD 201.63 billion in 2022 and is projected to hit around USD 634.64 billion by 2032, poised to grow at a CAGR of 12.2% over the forecast period from 2023 to 2032
https://www.biospace.com/article/releases/cancer-monoclonal-antibodies-market-size-estimated-to-reach-usd-410-95-billion-by-2032/
Fusion Antibodies FAB just needs 1% of that $200 billion dollar market, that's is unbelievable amount of money
$200B at 1% is$2 Billion
wow!!!!
just need 1% market share and FAB would be worth billion Mcap company!
Has anyone seen this
Monoclonal Antibodies Market: The global monoclonal antibodies market size accounted for USD 201.63 billion in 2022 and is projected to hit around USD 634.64 billion by 2032, poised to grow at a CAGR of 12.2% over the forecast period from 2023 to 2032
https://www.biospace.com/article/releases/cancer-monoclonal-antibodies-market-size-estimated-to-reach-usd-410-95-billion-by-2032/
Could be buys because part of midday onwards It was NT to buy,
hmm... could mms facilitated these 3X 250k buys?
upwards and onwards....
Imho..both ways are excellent 👌..if sells,that's mean less placing shares left..if buys....tomorow we will launch into space!!!
Those last 3 trades sells or buys????.....anyway..we find out tomorrow 🤔
Time for Fusion Antibodies FAB to get some big contracts from the USA.
With £500billion Monoclonal Antibodies Market Size Worth, won't be hard for FAB to get £100m contract.
just matter of time
Easy...3.97p."skolko godno""